Article info

PDF
Long-term safety and efficacy of ziv-aflibercept in retinal diseases

Authors

  1. Correspondence to Dr Jay Chhablani, Smt. Kanuri Santhamma Centre for Vitreoretinal Diseases, LV Prasad Eye Institute, Banjara Hills, Hyderabad, AP 500034, India; jay.chhablani{at}gmail.com
View Full Text

Citation

Mansour AM, Ashraf M, Dedhia CJ, et al
Long-term safety and efficacy of ziv-aflibercept in retinal diseases

Publication history

  • Received October 11, 2016
  • Revised January 10, 2017
  • Accepted February 11, 2017
  • First published March 7, 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.